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Abstract
Nowadays, screening uses the method of X-ray mammography for the early 
diagnosis of breast cancer. However, as a screening method, X-ray mammography 
has its limitations, such as age, periodicity of screening, ‘dense’ mammary gland 
and dynamic survey (repeated radiation). In order to overpass these limitations, 
more advanced alternative methods of breast examination should be used, which 
would be as effective as the ‘golden standard.’ Characteristics of electroimpedance 
diagnostics are given. The aim of screening is to detect breast cancer including early 
breast cancer (tumor size below 1 cm) and to form a survey of high-risk group. In 
order to reach these aims, the following actions need to be undertaken: search for 
areas with anomalous conductivity, detection of distorted mammographic scheme 
and evaluation of age-related electrical conductivity. The application of a scale for 
age-related breast conductivity with defined percentile limits allows to organize a 
survey group. Electrical properties of a cancerous tumor differ significantly from 
those of the surrounding tissues. Statistics of anomalous conductivity in cases of 
breast cancer is given. The disease development connected with the destruction of 
epithelial basement membrane is linked with various phenomena occurring in the 
tumor and the surrounding tissues. Statistics of disrupted mammographic scheme 
in cases of cancer is given.
Keywords: electroimpedance mammography, breast cancer, survey group, mammary 
gland structure, age-related electrical conductivity, anomalous conductivity, 
distorted mammographic scheme
1. Introduction: problems of breast cancer screening
In 1968 James Maxwell Glover Wilson and Gunnar Jungner supported by the 
World Health Organization published a research named [1]. In 1972 the American 
Cancer Society together with the National Cancer Institute developed the Breast 
Cancer Detection Demonstration Project, aimed to perform X-ray mammography 
breast cancer screening for more than quarter of a million of American women.
Since then, X-ray mammography has become not only the main screening 
method but also the ‘gold’ standard in diagnostics. It is important to distinguish the 
difference between screening tests and early diagnostics. Early diagnostics implies 
early detection of tumors in patients with symptoms. Screening test means early 
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detection of tumors in patients without symptoms [2]. Nowadays, screening uses 
X-ray mammography as the method of early diagnostics of breast cancer. However, 
used as a screening method, X-ray mammography has its limitations and draw-
backs. We’ll name some problems of the main screening method.
Age. Women aged below 40 usually do not undergo breast cancer screening 
since sensitivity of mammography is low in this population due to the high density 
of breast tissue [3]. It was discovered that mammographic screening under the age 
of 50 is not only less effective than in the elder age but is also related to higher radia-
tion risks [4]. Shifting of screening to the age range below 40 is undesirable since 
it will lead to the increase of patients’ radiation exposure. Age limitations for X-ray 
mammography are closely related to breast cancer morbidity.
Morbidity. According to the data of the Health and Social Care Information 
Centre [5], despite screening programs, breast cancer morbidity does not decrease; 
it remained on the same level for all age groups for 10 years since 2004–2005 till 
2014–2015 (Table 1). For the sake of solving the problem of morbidity, it would 
seem only natural to shift the screening framework down along the age scale. But 
age limitations do not allow for that.
Operational characteristics (sensitivity and specificity). Screening survey 
is a survey with low prevalence. As a rule, a low-prevalence survey is a preven-
tive checkup. Screening survey is characterized by unrestricted sampling, usually 
estimated in many thousands, by low prevalence, standardized procedure, signifi-
cant predominance of healthy patients over patients with pathologies, impossibility 
to use a reference method and histological verification of diagnosis due to a large 
number of healthy patients, significant predominance of early stage of disease 
among the affected patients and impossibility to apply operational characteristics, 
i.e. sensitivity and specificity. It is impossible to get operational characteristics and 
incidence data from the screening survey data. Operational characteristics can be 
received from the examination of patients with symptoms.
Table 2 shows operational characteristics of X-ray mammography received dur-
ing a 6-year period from a large group of patients with symptoms [6].
Sensitivity of X-ray mammography used for breast cancer diagnostics above 
80%, which would satisfy screening requirements, is observed only in the 70–79, 
80–89 and 90+ age groups.
Breast density. Breast cancer is often similar to X-ray density of fibroglandular 
tissue, which makes it difficult to distinguish these tissue types due to the masking 
effect of dense glandular tissue [7]. It explains the unreliability of X-ray mammog-
raphy for cancer diagnostics in women with high-density glandular parenchyma, 
with fibrocystic disease. Women with high mammographic density have higher 
Table 1. 
Women with cancer detected by age group.
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risk of breast cancer occurrence [8]. It has been proved that high mammographic 
density can be related to quadruple increase of breast cancer risk [9, 10].
Formation of survey or risk group. According to the definition of the World 
Health Organization, ‘there should be a recognizable latent or early symptomatic 
stage. The natural history of the condition, including the early stage, should be 
adequately understood.’ With the help of screening, it becomes possible to form 
breast cancer risk groups. Since ductal carcinoma takes origin from epithelial cells, 
areas with fibroglandular tissues and large amount of cells are highly susceptible to 
the increased epithelial proliferation [11]. It is the quantitative estimation of the state 
of fibroglandular tissue that should be used as the selection criterion allowing to 
differentiate the norm and the pathology. Patients with the amount of fibroglandular 
tissue abnormal for their age should become a part of the surveillance group. The 
existing screening methods do not allow to form breast cancer surveillance groups.
Repetitive examinations. Screening is a dynamic process. Recall of a patient 
for the screening program may cause anxiety or serious worries about potential 
illness, the so-called Ulysses syndrome, and lead to repeated radiation exposure 
[12]. In this connection, it is sensible to use safe screening methods that allow for 
multiple repetitive examinations. Frequency of examinations especially among 
high-risk group patients and in cases of hormone replacement therapy is chosen on 
an individual basis depending on the pathology detected.
Radiation exposure. Glandular tissue in the breast is most susceptible to 
radiation exposure compared to fat, skin and areola since immature cells are more 
vulnerable to ionizing radiation exposure [13]. And since ductal carcinoma takes 
origin from epithelial cells, it leaves one perplexed why X-ray mammography is 
used in breast cancer screening programs. Mammography has increased risks of 
radiation-induced breast cancer. Supposedly, low radiation dose is riskier than 
higher radiation dose [14, 15].
Rupture risk. The mammography procedure carries a risk of rupture of encap-
sulated cancer tumor, which may occur during the compression of breast tissue, 
and it may lead to metastases. Modern mammography equipment uses 42 pounds 
of pressure [16]. It may suffice for the disintegration of capsule and formation of 
metastases.
Mammography technique. According to the criteria of disease screening, 
the diagnostic method should be accessible and acceptable for the population [1]. 
Mammography technique can be evaluated through the analysis of the dose applied, 
the quality and size of the ray and the specific compression of breast. It has been 
established that the radiation dose and growth of breast cancer incidence are related 
[13]. Direct calculations of radiation dose (mGy) for a specific mammary gland are 
impossible. The difficulty lies in the knowledge of the structure of a specific mam-
mary gland, which is necessary for the calculation of the conversion ratio. For this 
Table 2. 
The number of patients attending the symptomatic breast clinic, by age and final diagnosis of either having 
breast cancer or not having breast cancer.
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reason, an average dose is used, which depends on the thickness of the breast. In 
modern mammographs, the exposition is selected automatically based on the thick-
ness of the compressed breast. Specific compression of the breast is the baseline for 
a good-quality image. Errors that may occur in the calculation of breast thickness 
during the compression of breast are related to the compression panel that may get 
bended and deformed.
These data show the necessity to implement additional effective screening 
programs for young women including screening with the application of alternative 
technology in order to lengthen the preclinical detection stage, which would lead to 
the decrease of breast cancer mortality rate [17]. In order to overcome the existing 
limitations, it is necessary to use modern alternative methods of breast examination 
that would be equal to the ‘gold’ standard in its effectiveness. Electrical impedance 
mammography is a diagnostic method satisfying the criteria set by the World Health 
Organization for screening for diseases. MEIK v.5.6, electrical impedance mammo-
graph developed and manufactured by PKF ‘Sim-technika,’ Russia, uses advanced 
technologies of imaging and processing of electrical impedance images of breast. It 
is a noninvasive technology of image creation, it uses 3D-tomography system, it is a 
form of ‘soft-field’ tomography, it applies ‘non-local’ method of tomographic image 
creation and cross-sectional approach to data collection, it uses back-projection 
method as the algorithm of image reconstruction, and finally it allows to receive 
quantitative diagnostic information. The electrical properties of biological tissue as of 
colloid-dispersed system in an alternating electric field depend on the concentration 
and behavior of the chemical components of the tissue. The electric properties of a 
tumor differ significantly from those of the surrounding tissues. The aim of screening 
is to detect breast cancer including early breast cancer (tumor size below 1 cm) and to 
form a survey or high-risk group. In order to reach these aims, the following actions 
need to be undertaken: search for areas with abnormal conductivity, detection of dis-
torted mammographic scheme and evaluation of age-related electrical conductivity.
2. Formation of survey group
Breast cancer risk factors. A notion exists of risk factors for breast cancer 
development. High breast density is one of the strongest risk factors for breast 
cancer development. Many of the stated risk factors for breast cancer influence 
breast density in the long run through hormones. Women with high breast density 
have higher concentration of estrogen in blood serum than women with lower 
breast density, and the risk of breast cancer for them is twice as high compared to 
the low level of circulating estrogens [18]. For women with extremely high breast 
density, the relative risk of breast cancer is four to eight times higher than high 
breast density or about two times higher than medium breast density [19]. Relative 
risk of breast cancer for women with extremely high breast density is 6.0 [with 95% 
confidence interval, 2.8–12.9], and it is the third risk factor after the patient’s sex 
and age [20]. Search for risk factors, diagnostics and preventive measures for high 
breast density forms a new field of research.
High breast density. Breast density is inversely proportional to the content of 
adipose tissue and directly proportional to the content of epithelial and fibrous 
tissue [21]. With advancing age, breast density decreases, and the breast tissue ‘ages’ 
[21]. Serial mammography showed that the initial breast density influences the 
change of density through life: age-related decrease of high density is stronger than 
the density decrease in cases of lower density [22]. It was found that there exists a 
relation between high breast density and hormonal status. The specific features of 
reproductive anamnesis, menstruation anamnesis, menopausal status, excessive 
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weight and exogenous and endogenous hormones influence breast density. Women 
with high breast density have higher concentration of estrogen in blood serum 
than women with lower breast density. Estrogen replacement therapy in pre- and 
postmenopausal period increases breast density [23–25]. Therefore, ‘breast density’ 
marker has higher potential as to being used for the prevention of breast cancer [26].
Methods of breast density estimation. Detecting women with high density of 
breast is the primary objective for screenings. Today there is no set ‘gold’ standard 
for the estimation of breast density. There are several methods for the assessment of 
breast density. Visual methods are based on the qualitative analysis of breast paren-
chyma, such as in Wolf’s, Tabàr’s, Boyde’s and BI-RADS classifications. The aim of 
semiautomatic estimation is to measure breast density. There exist automated systems 
for the estimation of the area of breast density. Volumetric methods allow to evaluate 
the actual volume of fibroglandular tissue. It should be noted that various methods of 
breast density measurement use only X-ray systems. There is a sharp need for addi-
tional screening of women with high breast density [27]. Due to the growing interest 
toward estimation of breast density, new diagnostic methods appear.
Electrical impedance estimation of breast structure. Biological tissue is 
presented as a colloidal dispersion system. The structure of breast has a number of 
tissues that fulfill different functions (epithelial tissues, connective tissues, nervous 
tissue, blood and lymph) and fill the anatomical structures. The electrical properties 
of tissues are the direct consequence of the tissue structure. The electrical impedance 
mammograph MEIK v.5.6. with current force 0.5 mA and frequency of 50 kHz allows 
to evaluate breast structure. The fundamental difference of electrical impedance 
scanning from other tomography methods is that besides visual evaluation of the 
image, the electrical impedance mammography provides quantitative informa-
tion, i.e. the numerical estimation of its anatomical and histological structure. This 
unique information is used for diagnostic purposes. All other factors equal, the 
electrical conductivity will depend on the concentration of ions and the amount of 
cellular elements, and it will decrease as the concentration grows [28]. The electrical 
conductivity index [IC], which is received during electric impedance scanning, is a 
quantitative characteristic of breast structure. Low index of electrical conductivity is 
typical for the breast containing a large amount of cellular elements and high con-
centration of ions, which corresponds to acinar-ductal type of breast structure. High 
electrical conductivity index is typical for the breast containing a large amount of fat 
lobules and connective tissue and low concentration of ions, which corresponds to 
amorphous structure of the breast. One thousand six hundred thirty-two processed 
images received from electromammographic examinations of healthy women helped 
to evaluate, percentile method applied, the structure of breast from the point of view 
of electrical impedance mammography. Table 3 shows percentile limits for different 
types of breast structure in electrical impedance mammography.
Therefore, the electrical conductivity index can be used for the evaluation of 
breast structure from the point of view of electrical impedance mammography. It is 
a known fact that the structure of breast defines the breast density. For this reason, 
the defined ranges of electrical conductivity correspond to different types of ‘den-
sity’ of breast. Table 4 shows the structure of the breast according to the electrical 
impedance mammography and types of density according to American College of 
Radiology [ACR] classification. ‘Dense’ breast, i.e. the so-called acinar-ductal type, 
is characterized by low electrical conductivity index. High electrical conductivity 
index is common for amorphous type of breast [consisting mostly of adipose and 
connective tissue]. The image shows examples of electrical impedance mammograms 
of patients from different age groups with different structure of breast: a 25-year-old 
patient with acinar-ductal type (Figure 1) and extreme breast density and 63-year-
old patient with amorphous structure and low breast density (Figure 2).
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On the Figure 2 you can find examples of electrical impedance mammograms 
of the same age group but with different breast structure: 36-year-old patient with 
acinar-ductal type and high tissue density and 34-year-old patient with amorphous 
structure and low tissue density (Figure 2). In order to form a survey group, it is 
necessary to determine not only the breast structure but also the correspondence 
between the structure type and age-related electrical conductivity of the breast.
Electrical impedance evaluation of age-related electrical conductivity of the 
breast. The application of percentile method for the electrical impedance mam-
mograms of healthy women in the following age ranges, <20, 20–29, 30–39, 40–49, 
50–59, 60–69 and >70 years old, allowed to evaluate age-related electrical conduc-
tivity of the breast from the point of view of electrical impedance mammography. 
For each age group, the 5th, 50th and 95th percentile limits of electrical conductiv-
ity were calculated. The data can be represented in the form of percentile curves of 
Table 4. 
The structure of the breast according to electrical impedance mammography and types of density according to 
the American College of Radiology [ACR] classification.
Definition Electrical 
conductivity
Percentile 
limits
Amorphous structure More than 0.66 >90‰
Mixed type with amorphous component prevailing 0.57–0.65 75–90‰
Mixed type 0.30–0.56 25–75‰
Mixed type with acinar-ductal component prevailing 0.22–0.29 10–25‰
Acinar-ductal type prevailing Less than 0.22 <10‰
Table 3. 
Percentile limits for different types of breast structure in electrical impedance mammography.
Figure 1. 
Type IV (ACR IV). Acinar-ductal type. Extreme tissue density.
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age-related electrical conductivity and in the form of a diagnostic table (Table 5). In 
accordance with the suggested estimations, the values in the 1st percentile corridor 
[below the 5th percentile] should be treated as significantly lowered, in the 2nd 
percentile corridor [5–25 percentile] as lowered, in the 3rd and 4th [25–75 percen-
tile] as medium, in the 5th [75–95 percentile] as increased and in the 6th [above 
the 95th percentile] as significantly increased. In order to form survey groups, it 
is necessary to use percentile limits of age-related electrical conductivity. The risk 
group should include the patients who have abnormally low values of age-related 
electrical conductivity of the breast, i.e. below the fifth percentile, which is the sig-
nal of high density of the acinar-ductal component of the breast for this age range. 
High density of acinar-ductal component is potentially dangerous since it may be 
combined with insufficient trophic function of connective tissue. It is a known fact 
that the ground substance of connective tissue plays the main role in the fulfillment 
of this function. Homeostasis disruption may lead to dystrophic processes including 
those in the basement membrane. Therefore, this method allows to detect the risk 
of tumorigenesis in women before the disease manifests itself, and it allows us to 
form risk groups for monitoring and correction of breast condition.
3. Early diagnostics of breast cancer
The electrical properties of cancer tumor differ greatly from the electrical prop-
erties of the surrounding tissues. It was established during several researches that 
malignant tumors have lower electrical impedance than normal tissues. The results 
of these studies are given in Table 6 [29].
S. Haltiwanger published the results of several studies about the specific features 
of tumor cells that influence their electrical activity:
Figure 2. 
Type I (ACR I). Amorphous type. Low tissue density.
Table 5. 
Diagnostic table of age-related electrical conductivity of breast.
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Authors, 
year
Frequency range 
investigated
Nature of study and results
Fricke et al. 
[29], 1926
20 kHz They measured the parallel capacitance and resistance of the 
following excised samples from the breast—fat, gland, mastitis, 
fibroadenoma and carcinoma They found significantly higher 
permittivity of the tumor tissue at 20 kHz than the normal or benign 
tissues.
Singh et al. 
[30], 1979
100 Hz–100 kHz They performed in vivo impedance measurements on female breasts 
with and without tumors. Their results showed that malignant 
tumors have higher relative permittivity and lower resistance than 
those of normal breast tissue
Chaudhary 
et al. [31], 
1984
3 MHz–3 GHz They examined excised normal and malignant breast tissues and 
found that the conductivity and permittivity of malignant tissues 
are higher than those of normal tissues, especially at frequencies 
lesser than 100 MHz.
Surowiec 
et al. [32], 
1988
20 kHz–100 MHz They conducted in vitro dielectric studies in three different samples 
of breast tissues—the main tumor tissue, the tissue immediately 
surrounding the tumor and the peripheral normal tissue. They found 
that the tumor tissues have a low-frequency (100 kHz) conductivity 
around 2–4 mS/cm which is higher than the conductivity of normal 
tissue (below 1 mS/cm) and lower than that of the tissue surrounding 
the tumor (8 mS/cm).
Morimoto 
et al. [33, 34], 
1990
0–200 kHz They measured the extracellular and intracellular resistances and 
membrane capacitance of breast tumors in vivo. They concluded 
that there are statistically significant differences between normal 
and cancerous tissues. However, it has been reported that malignant 
tumors have lowered capacitance compared to benign tumors. This 
is different from the results of the study conducted by Jossinet [36] 
and Fricke [33] which have recorded higher capacitance values for 
malignant tumors.
Jossinet [35], 
1996
488 Hz–1 MHz The study examined six groups of normal and pathological breast 
tissues in vitro. The variability of impedivity within each group was 
assessed by statistical methods. It was found that the variability was 
smaller in adipose tissue, carcinoma and fibroadenoma above 10 kHz.
Jossinet [36], 
1998
488 Hz–1 MHz Using the same data from [35], it was found that the cancerous 
tissue differed significantly from fibroadenoma and mammary 
gland tissues by the modulus of impedivity up to 31.25 kHz and 
from the remaining tissue groups (connective tissue, adipose 
tissue and mastopathy) by the low-frequency-limit resistivity and 
the phase angle from 125 kHz to 1 MHz. It was also observed that 
neither the impedivity nor the low-frequency-limit resistivity nor 
the fractional power value was different between the groups of 
normal and benign tissues.
Jossinet et al. 
[37], 1999
488 Hz–1 MHz Again using the same excised data collected for previous studies, 
they defined a set of eight parameters that could differentiate 
cancerous breast tissues from noncancerous ones. They concluded 
that a combination of the parameters over various frequencies is 
necessary for the accurate differentiation among tissues.
Chauveau 
et al. [38], 
1999
10 kHz–10 MHz They conducted an in vitro study of normal and pathological 
breast tissues and observed significant differences in their 
dielectric properties. They have determined three indices based 
on extracellular resistance, intracellular resistance and membrane 
capacitance to differentiate between various tissue pathologies—
normal, invasive ductal carcinoma (IDC), IDC with stromal 
reaction and fibrocystic changes.
Table 6. 
The results of several researches of the electrical properties of cancer tumor.
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1. Cancer cells have cell membranes that exhibit different electrochemical proper-
ties and a different distribution of electrical charges than normal tissues [30].
2. Cancer cells also have different lipid and sterol content than normal cells [31].
3. Cancer cells have altered membrane composition and membrane permeability, 
which results in the movement of potassium, magnesium and calcium out of 
the cell and the accumulation of sodium and water into the cell [32].
4. Cancer cells have lower potassium concentrations and higher sodium and 
water content than normal cells [33, 34].
5. The result of these mineral movements, membrane composition changes, 
energy abnormalities and membrane charge distribution abnormalities is a 
drop in the normal membrane potential and membrane capacitance.
6. An increase in the intracellular concentration of positively charged sodium 
ions and an increase in negative charges on the cell coat (glycocalyx) are two 
of the major factors causing cancerous cells to have lower membrane potential 
than healthy cells [31].
7. Two of the most outstanding electrical features of cancer cells are that they 
constantly maintain their membrane potential at a low value and their intracel-
lular concentration of sodium at a high concentration [34, 35].
8. A sustained elevation of intracellular sodium may act as a mitotic trigger caus-
ing cells to go into cell division [35].
The results of the researches confirm that electrical conductivity is an appropri-
ate parameter for the differentiation between healthy tissue and tumor tissue. The 
fundamental difference of electrical impedance scanning from other tomographic 
methods is that besides visual evaluation of the image, the electrical impedance 
mammography offers quantitative information [28]. If the diagnostic method under 
discussion yields a quantitative result, a value is defined, the overpassing of which is 
deemed to be a sufficient cause for qualitative evaluation, i.e. the so-called dif-
ferentiation point. It is essential to define a precise differentiation point. The point 
with electrical conductivity exceeding 3 standard deviations [std] is considered to 
be the point of differentiation between breast cancer patients and healthy people. 
The detection of areas with high electrical conductivity exceeding 3 std. outside the 
lactiferous sinus in electrical impedance mammograms, which differs greatly from 
the electrical conductivity of normal breast tissue, is used as a diagnostic criteria 
for the detection of breast cancer [28]. Moreover, sizes of tumors as a rule do not 
exceed 10 mm.
Figure 3 shows the electrical impedance mammogram of a breast cancer patient 
with the following parameters: IC = 0.56, std. = 0.12. In the mammogram, at the 3 
o’clock position near the areola, a focus without a sharp contour is visualized, its IC 
being equal to 0.94. Therefore, the IC in the area of interest exceeds the mammo-
gram IC by more than 3 std.
Below X-ray images [fibroadipose involution, the upper external quadrant shows 
a mass less than 1 cm in size with uneven contour] and ultrasound mammograms 
[the external quadrant contains a lesion of irregular shape with uneven structure, 
7 × 8 mm in size, with vascularization] of the same patient are presented.
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For the last few years, clinical studies have been held in different countries 
determining the potential of electrical impedance mammography in breast cancer 
diagnostics. All these studies used electrical impedance computer mammograph 
MEIK v.5.6, abnormal electrical conductivity being the diagnostic criterion [28].
Sachin Prasad and colleagues performed a study to determine the diagnostic 
efficiency of 3D electrical impedance tomography [EIT] compared to mam-
mography (mg) and ultrasonography (USG) in breast imaging [36]. A group of 
88 patients with various breast complaints was examined using combined mam-
mography and ultrasonography [MG & USG] or either of these modalities alone. 
The same patients were then examined using the 3D EIT imaging system MEIK. The 
study revealed that there was no overall significant difference in sensitivity between 
MG-USG [p = 0.219] and MG-EIT [p = 0.779] and USG-EIT [p = 0.169].
O. Raneta and colleagues [37] performed a study to analyze the possibilities of 
electrical impedance tomography [EIT] application in the differential diagnosis 
of pathologic lesions of the breast either solely or in combination with MMG/USG 
[37]. A group of 870 eligible women with suspected pathological breast lesion dis-
covered by mammography [MMG] or ultrasound examination [USG] were recom-
mended to pass histological examination to verify the diagnosis. The sensitivity of 
MMG increased from 87.8% when using it as an independent method to 94.5% with 
EIT added. The sensitivity of USG increased from 86.7% when used as an indepen-
dent method to 93.3% with EIT added. The results of the study showed that the use 
of EIT in addition to MMG/USG can improve the sensitivity of these methods and 
Figure 3. 
Upper row: Electrical impedance mammogram of a breast cancer patient. At the 3 o’clock position near the 
areola a focus without a sharp contour, with abnormal electrical conductivity, is visualized. It is colored red 
(7 × 10 mm). The lower row shows X-ray and ultrasound images for the same patient.
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increase the rate of early detection of breast cancer with minimal economic costs 
and time input of highly qualified staff.
Daglar and colleagues [38] performed a study to compare the usefulness of the 
breast electrical conductivity measures performed in a surgical examination room 
against conventional breast screening modalities for identifying the symptomatic 
lesions of the breast tissue [38]. A group of 181 patients were examined with 
ultrasonography [USG], mammography [MG] and electrical impedance scanning 
[EIS] modalities, which were followed up for 24 months to clarify the lesion tumor 
progression relationship. EIS exhibited compatible sensitivity [81.2%], accuracy 
[84.6%] and PPV [81.8%] rates with USG in BI-RADS 4 subgroup, combination of 
these modalities raised sensitivity rates to 92.31%, accuracy and PPV to 100%. EIS 
results in BI-RADS 3 subgroup were pointed out 77.8% specificity and 87.5% NPV 
rates. Breast electrical impedance measures should be useful to reduce the number 
of the unnecessary follow-up and biopsy rates in the clinical setting.
Xu Feng and colleagues [39] performed a study to investigate the diagnostic 
accuracy of electrical impedance tomography [EIT] for benign and malignant 
breast diseases in comparison to conventional ultrasonography and mammography 
[39]. A total of 121 patients with 126 breast lesions who underwent ultrasonogra-
phy mammography and EIT were enrolled in the study. All of these lesions were 
confirmed by pathological biopsy. The accuracy, sensitivity, specificity, positive 
predictive value and negative predictive value of EIT, ultrasonography and mam-
mography were calculated with histology used as the ‘gold’ standard. The accuracy 
of EIT, ultrasonography and mammography were 75.4, 81.7 and 76.1%, respectively. 
The sensitivity was 76.8, 94.6 and 74.4%, respectively. The specificity was 74.3, 71.4 
and 77.6%, respectively. The accuracy, sensitivity and specificity of EIT combined 
with ultrasound in the diagnosis of breast lesions were 91.3, 98.2 and 85.7%, respec-
tively. The accuracy [χ2 = 4.896, P = 0.027] and specificity [χ2 = 4.242, P = 0.039] 
were significantly higher on EIT than ultrasound. The accuracy, sensitivity and 
specificity of EIT combined with mammography were 95.5, 97.4 and 93.9%, respec-
tively, which were significantly higher than those of mammography [χ2 = 13.474, 
P < 0.001; χ2 = 8.573, P = 0.003; χ2 = 5.333, P = 0.021]. Used together with ultra-
sound or mammography, the electrical impedance tomography could be a valuable 
complementary examination in the diagnosis of breast diseases. Furthermore, EIT 
could provide very useful additional information for metabolic assessment of mam-
mary glands, which may be used for early screening of breast diseases.
Blanca Murillo-Ortiz and colleagues [40] performed a study to know the effec-
tiveness of the electrical impedance mammography for the detection of mammary 
carcinoma in 615 women from 25 to 70 years of age [40]. The sensitivity and 
specificity of the electrical impedance mammography (MEIK) was 85 and 97%, 
respectively.
Therefore, the studies showed high level of sensitivity and specificity, which 
allows to use abnormal electrical conductivity as the diagnostic criterion in screen-
ings for early detection of breast cancer.
4. Distorted mammographic scheme in cases of breast cancer
Distortion of normal mammographic scheme appears in case of structural 
changes, such as pathological shadows and microcalcifications. These focal changes 
can be easily detected with the help of medical equipment checking the density of 
tissue. But along with focal changes, breast cancer can reveal itself through diffuse 
changes of breast structure, which also leads to the disruption of normal mammo-
graphic scheme, and this can be detected with electrical impedance mammography. 
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For X-ray diagnostics, diffuse changes are a difficult matter since they do not 
change the density of breast tissue.
As the disease develops, which leads to the destruction of the basement mem-
brane of the epithelium, the lesion and surrounding tissues may undergo various 
phenomena followed by changes of electrical properties of the tumor mass:
• Edema and softening of fibrous connective tissue
• Slimming, hyalinosis, calcification
• Appearance of purulent areas
• Lymphocytic infiltration of tissue
Therefore, tumor growth is naturally accompanied by the changes of electrical 
properties of tumor and surrounding tissues. The criteria of distortion of normal 
mammographic scheme in cases of breast cancer are changes of contour, anatomical 
changes, local changes of electrical conductivity and change of comparative electrical 
conductivity. As previously stated, the electrical impedance method gives a possibility 
of quantitative imaging [28]. Quantitative analysis of an electrical impedance image 
allows to receive a histogram of electrical conductivity distribution and compares it 
with reference values. As a rule, distorted mammographic scheme in case of breast 
cancer is accompanied by changes of electrical conductivity of breast tissues. This phe-
nomenon facilitates visual and quantitative interpretation of the lesion and can be used 
for diagnostic purposes. Figure 4 shows several variants of distorted mammographic 
scheme in cases of breast cancer and their visual evaluation [1, contour deformation; 
2,4, thickening of contour; 3, anatomic distortion; 5,6, local changes].
For the classification of a patient (healthy or affected), test of differences in the 
form of distributions [λ criterion], i.e. Kolmogorov-Smirnov test in Dx modifica-
tion, is used [41]. This criterion, which is a nonparametric test, allows to determine 
the statistical value of differences in the distribution of any normal or abnormal 
features, including the distribution of electrical conductivity in electrical imped-
ance tomograms. For the assessment of informativeness of distribution divergence, 
Kulback informativeness measure is applied [41]. High informativeness of the 
detected differences allows to refer the patient with high degree of probability to 
one class or the other (e.g. norm or cancer). In case of breast cancer, histogram of 
affected breast gets displaced, and Dx criterion exceeds 40% (Figure 5).
Table 7 shows the comparative electrical conductivity data for patients with 
breast cancer, benign changes, for healthy patients and for those with different 
types of breast structure; the data was received during clinical studies in the hospi-
tals of Russia. It is evident that divergence of histograms of electrical conductivity 
distribution by more than 40% is observed only in cases of breast cancer, and actu-
ally divergence of histograms of electrical conductivity distribution by more than 
30% in the majority of cases is observed during oncological processes in the breast.
Figure 4. 
Several variants of distorted mammographic scheme in cases of breast cancer.
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Figure 5. 
Upper row, EIM. Seven scan planes. Breast cancer. Bottom row, EIM. Seven scan planes. Healthy breast. The 
second row shows the divergence between the histograms of electrical conductivity distribution of the affected 
and healthy breast.
Table 7. 
Percentage distribution of healthy patients, patients with benign changes and breast cancer depending on the 
percentage of comparative electrical conductivity of the breasts.
EIM ACR
Common scale BI-RADS categories
No score BI-RADS 0 poor image
0–1 BI-RADS 1 lesion is not defined
2–3 BI-RADS 2 benign tumors—routine mammography
4 BI-RADS 3 probably benign findings
5–7 BI-RADS 4 suspicious abnormality—biopsy
>8 BI-RADS 5 highly suggestive of malignancy—treatment/biopsy
Table 8. 
EIM scale and ACR BI-RADS.
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During the oncological process, natural changes of general and local electrical 
conductivity occur. And distortion of normal mammographic scheme may occur at 
an early stage of the disease. This is the reason why this criterion is included in the 
EIM scale of breast cancer diagnostics [41].
A scoring scale used for the evaluation of mass lesions in the breast by means 
of electrical impedance mammography allowed to relate the information received 
with BI-RADS ACR categorization (Table 8). The EIM scoring scale allowed to 
standardize the description of mass lesions examined by means of electrical imped-
ance mammography and to use the patient follow-up algorithm developed by the 
American College of Radiology.
Therefore, the distortion of normal mammographic scheme along with abnormal 
electrical conductivity is one of the most frequent diagnostic indicators of breast cancer.
5. Discussion
Sensitivity and specificity are operational characteristics that allow to evaluate 
the effectiveness of a diagnostic method. Operational characteristics are influenced 
by several factors: size and area of pathology, age of patients in the groups under 
study and prevalence in the group under study. In the process of sensitivity and 
specificity calculation, the disease prevalence in the group is not taken into account. 
It is a significant benefit since it gives a possibility to spread the data received in a 
group of people onto other groups, with different prevalence. However, it is also a 
drawback of evaluation. The diagnostic test data should be spread cautiously onto 
groups of people that differ significantly from the group under study.
The calculation method used for operational characteristics such as sensitivity 
and specificity has its own peculiarities in cases of low and high prevalence.
Low-prevalence studies. As a rule, studies with low prevalence are preventive 
checkups. Screenings are low-prevalence studies as well.
Characteristics of screenings:
• Unrestricted population of sampling group, as a rule including many thou-
sands of people
• Low prevalence
• Standard methodology
• Significant prevailing of healthy patients over patients with pathologies
• Impossibility to use reference method and histological verification of the 
diagnosis due to a large number of healthy patients
• Significant prevailing of patients with early stages of disease from among the 
number of those with revealed pathologies
• Impossibility to apply operational characteristics: specificity and sensitivity
High-prevalence studies. Studies performed in a diagnostic department of a 
specialized clinic are high-prevalence studies.
Characteristics of a diagnostic study:
• Restricted sampling population, several dozens of respondents
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• High prevalence
• Standardized methodology
• Significant prevailing of patients with pathologies over healthy ones
• Significant prevailing of patients with progressing disease over those with 
early stages
• Use of referential method and histological verification of diagnosis
• Application of operational characteristics: sensitivity and specificity
Medium prevalence, which can be called an intermediate link, is a study held in 
a diagnostics department of a general practice clinic.
Characteristics of a diagnostic study:
• Unrestricted sampling population and timing
• Medium prevalence
• Standardized methodology
• Prevailing of healthy patients over patients with pathologies
• Full range of disease manifestation: from early-stage patients to patients with 
progressing disease
• Use of referential method and histological verification of diagnosis
• Application of operational characteristics: specificity and sensitivity
Is it correct to spread operational characteristics received from the second and 
third examples onto the screening?
1. Spreading the estimations received in high-prevalence conditions onto low-preva-
lence conditions should be done with caution. High-prevalence spectrum of disease 
manifestations differs from low-prevalence spectrum. Since diagnostic centers 
accumulate patients with a certain disease, in the structure of high-prevalence cases 
of progressing disease dominate significantly over early stages of disease.
2. Since every stage of disease has its own symptoms or specific criteria, for every 
stage the diagnostic criteria should have their own operational characteristics.
3. Operational characteristics are determined on the basis of restricted sample 
group of patients with verified diagnoses. Since reference tests, as a rule, are 
indifferent for the respondents, in such studies the number of persons not 
affected by the disease under study is minimal. In case of data spreading, it can 
influence the expected number of false-positive and false-negative results.
4. The optimal study for receiving operational characteristics of the method used 
from the point of view of patient selection, prevalence level, from the point of 
view of commonality of the methodology used and the usage of the reference 
Breast Cancer and Breast Reconstruction
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method and histological verification is not a low-prevalence study, such as 
screening, and is not a high-prevalence study as inpatient examination but a 
study held in an imaging room for the prevalence typical for the settlement. 
Shifting of operational characteristics in the situation of medium prevalence is 
preferable since it has a well-balanced data set.
Electrical impedance mammography is a tool for primary breast cancer screen-
ing. It is confirmed by its high informativeness, safety for the staff and patient, 
portability and mobility. Operational characteristics (sensitivity and specificity) are 
determined on a restricted sample group, the so-called high- and medium-preva-
lence group, with the use of reference method (X-ray mammography) and verified 
diagnosis. The studies were held in oncological centers and clinics. The study on a 
group of patients with high and medium prevalence demonstrated high sensitivity 
and specificity of the electrical impedance mammography. The received operational 
characteristics can be spread onto groups of patients with low prevalence and be 
used during planning of screening studies. It allows to use the electrical impedance 
mammography for primary breast cancer screening of big groups of population 
with low prevalence. The electrical impedance mammography fulfills its functional 
screening tasks without ionizing radiation and other potentially hazardous means. 
It can be used to perform examinations for women of all age groups in outpatient 
departments, schools, clinics for women, maternity hospitals and sanatoriums, i.e. 
in the gathering places for women. In such a way, the problem of organization of 
mass screening for women can easily be solved.
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